TCM
EDIT icon

Teza Capital Management’s Editas Medicine EDIT Stock Holding History

Teza Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,872
Closed -$27.7K – 363
2025
Q1 		$27.7K Sell
23,872
-2
-0% -$3 0.01% 403
2024
Q4 		$30.3K Buy
23,874
+2
+0% +$5 ﹤0.01% 467
2024
Q3 		$81.4K Sell
23,872
-1,416
-6% -$6.16K 0.01% 573
2024
Q2 		$118K Sell
25,288
-6,706
-21% -$37.8K 0.01% 548
2024
Q1 		$237K Buy
31,994
+21,137
+195% +$176K 0.03% 482
2023
Q4 		$110K Buy
+10,857
New +$95.3K 0.02% 524

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Teza Capital Management's EDIT Position: Q2 2025 in Review

Teza Capital Management sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 23,872 shares — an estimated $27.7K sold.

Teza Capital Management first reported a position in EDIT in Q4 2023 and held it in 6 quarters. The position peaked at $237K in Q1 2024. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • Teza Capital Management reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
  • Teza Capital Management sold 23,872 Editas Medicine shares in Q2 2025, an estimated $27.7K.
  • Teza Capital Management first reported a position in Editas Medicine in Q4 2023 and held it in 6 quarters.
  • Teza Capital Management's Editas Medicine position peaked at $237K in Q1 2024.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Teza Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.